Prime Medicine Inc (PRME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 209 | 0 | 591 | 0 | 0 |
| Gross Profit | 209 | N/A | 591 | N/A | N/A |
| Operating Expenses | 54,441 | 55,672 | 48,932 | 68,043 | 51,459 |
| Operating Income | -54,232 | -55,672 | -48,341 | -68,043 | -51,459 |
| Other Income | 1,714 | 211 | 2,714 | 2,400 | 643 |
| Pre-tax Income | -52,518 | -55,461 | -45,627 | -65,643 | -50,816 |
| Income Tax | N/A | -134 | 134 | N/A | -108 |
| Net Income Continuous | -52,518 | -55,327 | -45,761 | -65,643 | -50,708 |
| Net Income | $-52,518 | $-55,327 | $-45,761 | $-65,643 | $-50,708 |
| EPS Basic Total Ops | -0.44 | -0.46 | -0.44 | -0.72 | -0.55 |
| EPS Basic Continuous Ops | -0.44 | -0.46 | -0.44 | -0.72 | -0.55 |
| EPS Diluted Total Ops | -0.44 | -0.46 | -0.44 | -0.72 | -0.55 |
| EPS Diluted Continuous Ops | -0.44 | -0.46 | -0.44 | -0.72 | -0.55 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.46 | -0.44 | N/A | N/A |
| EBITDA(a) | $-53,544 | $-55,538 | $-47,701 | $-67,884 | $-51,140 |